Scott Shoemaker
About Scott Shoemaker
Scott Shoemaker is the Senior Vice President of Quality at bluebird bio, with a background in chemical engineering and extensive experience in pharmaceutical leadership.
Scott Shoemaker Company
Scott Shoemaker is currently with bluebird bio, where he has been employed since 2017. Bluebird bio is a biotechnology company that focuses on developing gene therapies for severe genetic diseases and cancer. At bluebird bio, Scott contributes his extensive experience in quality assurance and operational management, leveraging his technical background in chemical engineering.
Scott Shoemaker Title
Scott Shoemaker holds the title of Senior Vice President of Quality at bluebird bio. In this executive role, he oversees the company’s quality management systems and ensures compliance with regulatory standards. His responsibilities likely include the development and implementation of quality strategies to guarantee the safety and efficacy of bluebird bio's gene therapy products.
Scott Shoemaker Education and Expertise
Scott Shoemaker is a chemical engineer by training, having earned a Bachelor of Science degree from Drexel University. He further advanced his education with a PhD in Chemical Engineering from Princeton University. His academic background provides a strong foundation for his expertise in quality management within the biotechnology and pharmaceutical industries.
Scott Shoemaker Background
Before joining bluebird bio in 2017, Scott Shoemaker held leadership positions at both Merck and Takeda. His roles at these companies were focused on development, technical operations, and manufacturing, particularly relating to live virus vaccine products. This experience has equipped him with significant expertise in handling complex biotechnology processes and regulatory standards.